Traws Pharma, Inc. (NASDAQ: TRAW) has finalized agreements to raise up to $72.6 million to support the development of its ...
Cocrystal Pharma shares dropped after the company said it planned to extend a study of an oral treatment for influenza because of an unexpectedly low rate of infection in participants challenged with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback